ArticleThe oncologist2021

Safety and Efficacy of First-Line Pembrolizumab in Black Patients with Metastatic Non-Small Cell Lung Cancer.

Monica Peravali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.